Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
종목 코드 SRTS
회사 이름Sensus Healthcare Inc
상장일Jun 03, 2016
CEOSardano (Joseph C)
직원 수35
유형Ordinary Share
회계 연도 종료Jun 03
주소851 Broken Sound Pkwy NW Ste 215
도시BOCA RATON
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호33487-3635
전화15619225808
웹사이트https://sensushealthcare.com/
종목 코드 SRTS
상장일Jun 03, 2016
CEOSardano (Joseph C)
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음